AKT1 and neoplasm: The E6 and E7 oncoproteins disrupt tumour-related signalling pathways including Wnt/β-catenin, PI3K/Akt and NF-kB which leads to the dysregulation of essential molecular pathways in host cells through interactions with critical cellular components that control cell cycle progression and result in malignant transformation.18